(Updated - April 28, 2026 6:39 AM EDT)
GMR Solutions has filed paperwork for a proposed initial public offering on the New York Stock Exchange, according to its public filing. The company describes itself as a large provider of emergency medical services and an integrated operator of alternate-site, out-of-hospital care in the U.S., with substantial scale and a broad clinical presence.
"We are the largest provider of emergency medical services ("EMS") and one of the largest integrated providers of essential alternate-site, out-of-hospital care in the United States, and are one of the largest mobile clinical practice groups globally. We care for patients when they need us most - whether at home, at the site of an accident, while attending an event or in other settings where time-sensitive care is needed. As the entry point for patients into the healthcare system, we deploy our expertly trained and credentialed clinical teams to provide on-site care, and if necessary, transport patients to the most appropriate healthcare facility, or, if the patient is non-emergent, navigate the patient to a less acute setting. As the only national, fully-integrated air and ground EMS provider, our operations span approximately 1,400 U.S. counties, covering both rural and urban communities which are home to more than 60% of the U.S. population as of December 31, 2025. We are at the front line of the healthcare continuum, encountering approximately 15,000 patients per day or approximately 5.5 million patients annually and our clinicians perform a critical care intervention every 89 seconds. Because of our scale, we have a data set of more than 80 million patient care records, which we use to track care processes and patient outcomes, and identify the most effective methods for patient care. Our team of more than 24,000 clinicians serves as the first line of care, providing lifesaving treatment at crucial moments. We maintain longstanding relationships across the healthcare ecosystem, serving local communities, health systems, payors, public health and local, state and federal agencies. We believe that our robust scale, relationships, and clinical, operational and logistical capabilities make us a leader in essential alternate-site, out-of-hospital care."
The filing names J.P. Morgan, KKR and BofA Securities as the lead underwriters for the proposed offering. Beyond the underwriting appointments and the company description cited above, the filing included no additional offering terms in the material provided here.
Context from the filing
- The company reports that it operates both air and ground EMS services nationally, and describes itself as the only national, fully-integrated air and ground EMS provider.
- Operations are stated to span roughly 1,400 U.S. counties and to cover communities that collectively house more than 60% of the U.S. population as of December 31, 2025.
- Clinical activity is reported at approximately 15,000 patients per day, or about 5.5 million patients annually, with a critical care intervention occurring every 89 seconds.
- GMR states it has a data set exceeding 80 million patient care records and a workforce of more than 24,000 clinicians.
- The filing indicates longstanding relationships across local communities, health systems, payors, public health and government agencies.
What the filing does not disclose here
The public material supplied in connection with the filing, as cited above, does not include offering size, proposed share price, expected timing for the offering, or other deal economics. Those details typically appear in subsequent prospectus supplements or amendments, which are not part of the information provided in this filing excerpt.
Implications for markets and stakeholders
The filing signals GMR Solutions' intent to access public markets, with lead underwriters in place. Market participants tracking healthcare services, emergency medical providers and companies operating at the intersection of clinical care and logistics are likely to monitor further filings for financial details and timing. The document highlights operational scale, clinical throughput and a substantial repository of patient care data as key company characteristics.
Further updates, including definitive offering terms and any financial performance disclosures, will be required to assess valuation and potential investor impact.